Ticker: SLXN

Silexion Therapeutics Corp (NASDAQ: SLXN) is navigating the complexities of the biotechnology sector as it works on developing advanced treatments for pancreatic cancer. The latest quarterly report provides a detailed insight into its financial health and operational challenges. Key Highlights fr...